Results 201 to 210 of about 4,579,575 (247)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Pediatric Tuberculosis Care Outcomes in a Tertiary Care Center, France, 2014-2024. [PDF]

open access: yesEmerg Infect Dis
Franco D   +5 more
europepmc   +1 more source

A Retrospective Analysis Examining the Impact of Educational Attainment and Social Determinants of Health on Rifampicin-Resistant Tuberculosis Treatment Outcomes. [PDF]

open access: yesOpen Forum Infect Dis
Teibo TKA   +16 more
europepmc   +1 more source

Harnessing routinely collected data for the evaluation of early years interventions: insights from a scoping review of evaluation studies.

open access: yesInt J Popul Data Sci
Mooney KE   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy